Availability of Transgene’s 2024 Universal Registration Document (URD)

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer,announces that the French version of its 2024 Universal Registration Documentwas filed with the French Financial Markets Authority(Autorité des marchés financiers – AMF) on April 10, 2025, under number D.25-0243.

This document, available on the AMF’s website (www.amf-france.org), can be viewed and downloaded (in PDF format in French and English, and in ESEF format in French only) on Transgene’s website (www.transgene.fr)

It includes the following documents:

• the Annual Financial Report;
• the Board of Directors’ Corporate Governance Report;
• the Statutory Auditors’ Reports;
• information on the Company’s share capital, including the share buyback program;
• information on the Statutory Auditors’ fees.

The Universal Registration Document also includes information on the Company’s Environmental, Social and Governance (ESG) factors.

Attachment

• 20250410_Transgene_publication_URD_2024_EN

© 2025 GlobeNewswire, Inc. All Rights Reserved.

Read More..

The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.